Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$0.3 - $0.61 $26,741 - $54,374
-89,138 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$0.55 - $1.04 $145,753 - $275,607
-265,007 Reduced 74.83%
89,138 $49,000
Q3 2021

Nov 15, 2021

SELL
$1.06 - $1.52 $137,602 - $197,317
-129,814 Reduced 26.82%
354,145 $375,000
Q2 2021

Aug 16, 2021

BUY
$1.22 - $1.65 $590,429 - $798,532
483,959 New
483,959 $731,000
Q3 2020

Nov 16, 2020

SELL
$1.7 - $6.41 $31,790 - $119,867
-18,700 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$0.87 - $2.46 $16,269 - $46,002
18,700 New
18,700 $42,000

About iBio, Inc.


  • Ticker IBIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,006,580
  • Market Cap $23.7M
  • Description
  • iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...
More about IBIO
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.